冠状动脉CT血管造影中的肝脂肪变性与心包脂肪及其与冠状动脉疾病的关系
回顾性分析331例连续患者的冠状动脉CT血管造影图像,测量心外膜脂肪组织、心包脂肪组织面积及肝脏衰减值。肝脂肪变性组中重度钙化评分比例显著更高,心外膜脂肪与心包脂肪在肝脂肪变性组及冠心病患者中均显著更高;心包脂肪测量在有无冠心病者间差异显著,作者认为心外膜和心包脂肪可能比肝脂肪变性更有助于评估冠心病风险。
要点
- 心包脂肪与心外膜脂肪在冠心病患者中均显著高于无冠心病者(两位阅片者均P<0.05)。
- 肝脂肪变性组中度及重度钙化评分患者比例显著高于无脂肪变性组(P=0.016)。
- 冠心病存在或严重程度与肝脂肪变性无相关性,但心包脂肪在有无冠心病者间差异显著。
核心结论
- 心外膜脂肪和心包脂肪测量可能比肝脂肪变性更有助于评估冠心病风险,可能作为判断冠心病存在及严重程度的独立标志物。
研究设计与样本
- 回顾性分析331例连续患者的冠状动脉CT血管造影图像,测量心外膜脂肪面积、心包脂肪面积及肝脏衰减值,评估冠状动脉狭窄的存在与严重程度并计算冠状动脉钙化负荷。
关键影像表现/征象
- 肝脂肪变性组心外膜脂肪和心包脂肪值在两位阅片者中均显著高于无肝脂肪变性组(P<0.05)。
- 冠心病患者心外膜脂肪和心包脂肪值在两位阅片者中均显著高于无冠心病者(P<0.05)。
- 冠状动脉疾病的存在或严重程度与肝脂肪变性之间未观察到相关性。
诊断标准与关键数值
- 肝脂肪变性组中度及重度钙化评分患者比例显著高于无肝脂肪变性组(P=0.016)。
- 逻辑回归分析显示心包脂肪测量在有无冠心病个体间显著不同,两位阅片者结果一致。
临床应用与阅片要点
- 在冠状动脉CT血管造影阅片时可同时测量心外膜脂肪和心包脂肪面积,作为评估冠心病风险的参考指标。
- 肝脂肪变性在冠状动脉CT血管造影上可评估,但与冠心病存在及严重程度无相关性,评估冠心病风险时心外膜脂肪和心包脂肪可能更有价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: The aim of this study was to evaluate the association of both hepatosteatosis and epicardial adipose tissue (EAT) and paracardial adipose tissue (PAT) with coronary artery disease (CAD).
MATERIALS AND METHODS: The coronary computed tomography angiography (CCTA) images of 331 consecutive patients were retrospectively analysed. Epicardial and paracardial fat areas and hepatic attenuation values were measured on the same images. The presence and severity of coronary artery stenosis were assessed, and the coronary calcium burden was calculated.
RESULTS: No correlation was observed between the presence or severity of CAD and steatosis in either group. However, the proportion of patients with moderate and severe calcium scores was significantly higher in the steatosis group (P=0.016). EAT and PAT values were statistically significantly higher in the steatosis group than in the nonsteatosis group across both readers (P<0.05). Similarly, in patients with CAD, EAT and PAT values were statistically significantly higher than in those without CAD across both readers (P<0.05). The logistic regression analysis showed that PAT measurements significantly differed between individuals with and without CAD, with consistent results from both readers.
CONCLUSION: EAT and PAT values may be considered more useful than hepatosteatosis in assessing the risk of CAD. These parameters could serve as independent markers for determining the presence and severity of CAD.
引用
- Konukoglu O, Kaya M, Gungor C, et al. Hepatic and pericardial fat in coronary computed tomography angiography and its association with coronary artery disease. Clin Radiol. 2025. PMID: 41072273. doi:10.1016/j.crad.2025.107080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。